Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects.

MLA

Rio, G.Del, et al. “Cholinergic Enhancement by Pyridostigmine Increases the Insulin Response to Glucose Load in Obese Patients but Not in Normal Subjects.” International Journal of Obesity & Related Metabolic Disorders, vol. 21, no. 12, Dec. 1997, p. 1111. EBSCOhost, https://doi.org/10.1038/sj.ijo.0800523.

APA

Rio, G. D., Procopio, M., Bondi, M., Marrama, P., Menozzi, R., Oleandri, S. E., Grottoli, S., Maccario, M., Velardo, A., & Ghigo, E. (1997). Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects. International Journal of Obesity & Related Metabolic Disorders, 21(12), 1111. https://doi.org/10.1038/sj.ijo.0800523

Chicago

Rio, G Del, M Procopio, M Bondi, P Marrama, R Menozzi, S E Oleandri, S Grottoli, M Maccario, A Velardo, and E Ghigo. 1997. “Cholinergic Enhancement by Pyridostigmine Increases the Insulin Response to Glucose Load in Obese Patients but Not in Normal Subjects.” International Journal of Obesity & Related Metabolic Disorders 21 (12): 1111. doi:10.1038/sj.ijo.0800523.